Correlation Between Cannara Biotech and IShares SPTSX

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and IShares SPTSX at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and IShares SPTSX into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and iShares SPTSX Capped, you can compare the effects of market volatilities on Cannara Biotech and IShares SPTSX and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of IShares SPTSX. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and IShares SPTSX.

Diversification Opportunities for Cannara Biotech and IShares SPTSX

-0.17

Correlation Coefficient

Cannara Biotech  IShares SPTSX

Good diversification

The 3 months correlation between Cannara and IShares is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and iShares SPTSX Capped in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares SPTSX Capped and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with IShares SPTSX. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares SPTSX Capped has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and IShares SPTSX go up and down completely randomly.

Pair Corralation between Cannara Biotech and IShares SPTSX

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 1.22 times less return on investment than IShares SPTSX. In addition to that, Cannara Biotech is 2.94 times more volatile than iShares SPTSX Capped. It trades about 0.01 of its total potential returns per unit of risk. iShares SPTSX Capped is currently generating about 0.05 per unit of volatility. If you would invest  1,330  in iShares SPTSX Capped on September 25, 2024 and sell it today you would earn a total of  347.00  from holding iShares SPTSX Capped or generate 26.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.76%
Values	Daily Returns

Cannara Biotech  vs.  iShares SPTSX Capped

Cannara Biotech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

iShares SPTSX Capped

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares SPTSX Capped has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy technical and fundamental indicators, IShares SPTSX is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Cannara Biotech and IShares SPTSX

The main advantage of trading using opposite Cannara Biotech and IShares SPTSX positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, IShares SPTSX can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares SPTSX will offset losses from the drop in IShares SPTSX's long position.

The idea behind Cannara Biotech and iShares SPTSX Capped pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.